{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T11:04:24Z","timestamp":1788260664461,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,21]],"date-time":"2026-02-21T00:00:00Z","timestamp":1771632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100017784","name":"Gilead Research Scholars Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0310545"],"award-info":[{"award-number":["JP25fk0310545"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP24fk0210121"],"award-info":[{"award-number":["JP24fk0210121"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0210174"],"award-info":[{"award-number":["JP25fk0210174"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0210123"],"award-info":[{"award-number":["JP25fk0210123"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0310551"],"award-info":[{"award-number":["JP25fk0310551"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0310535"],"award-info":[{"award-number":["JP25fk0310535"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0210172"],"award-info":[{"award-number":["JP25fk0210172"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0210142"],"award-info":[{"award-number":["JP25fk0210142"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0210126"],"award-info":[{"award-number":["JP25fk0210126"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0210157"],"award-info":[{"award-number":["JP25fk0210157"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0310543"],"award-info":[{"award-number":["JP25fk0310543"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP25fk0210143"],"award-info":[{"award-number":["JP25fk0210143"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journalofinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/j.jinf.2026.106715","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T17:06:41Z","timestamp":1772125601000},"page":"106715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Tenofovir alafenamide prevents HBV reactivation in anticancer\/immunosuppression: 24-month multicentre prospective study"],"prefix":"10.1016","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0098-9106","authenticated-orcid":false,"given":"Goki","family":"Suda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4366-3184","authenticated-orcid":false,"given":"Masatsugu","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiya","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonoe","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingjie","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zijian","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hidetaka","family":"Hosono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Yokoyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takatsugu","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akimitsu","family":"Meno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naohiro","family":"Yasuura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kitagataya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Kawagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Sho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Maehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1194-4149","authenticated-orcid":false,"given":"Shunsuke","family":"Ohnishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takaaki","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Meguro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Terashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomofumi","family":"Takagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoe","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Izumi","family":"Tsunematsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoya","family":"Sakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10","key":"10.1016\/j.jinf.2026.106715_bib1","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2468-1253(23)00197-8","article-title":"Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling study","volume":"8","author":"Polaris Observatory","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"9959","key":"10.1016\/j.jinf.2026.106715_bib2","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(14)60220-8","article-title":"Hepatitis B virus infection","volume":"384","author":"Trepo","year":"2014","journal-title":"Lancet"},{"issue":"22","key":"10.1016\/j.jinf.2026.106715_bib3","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1200\/JCO.2012.48.5938","article-title":"Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B","volume":"31","author":"Huang","year":"2013","journal-title":"J Clin Oncol"},{"issue":"1","key":"10.1016\/j.jinf.2026.106715_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1053\/j.gastro.2006.04.015","article-title":"Kinetics and risk of de novo hepatitis B infection in HBsAg-negative patients undergoing cytotoxic chemotherapy","volume":"131","author":"Hui","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.jinf.2026.106715_bib5","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1086\/590968","article-title":"Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan","volume":"47","author":"Umemura","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"4","key":"10.1016\/j.jinf.2026.106715_bib6","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1002\/hep.29800","article-title":"Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance","volume":"67","author":"Terrault","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.jinf.2026.106715_bib7","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"EASL clinical practice guidelines on the management of hepatitis B virus infection","volume":"83","author":"European Association for the Study of the L","year":"2025","journal-title":"J Hepatol"},{"issue":"31","key":"10.1016\/j.jinf.2026.106715_bib8","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1200\/JCO.20.01757","article-title":"Hepatitis B virus screening and management for patients with cancer prior to therapy: ASCO provisional clinical opinion update","volume":"38","author":"Hwang","year":"2020","journal-title":"J Clin Oncol"},{"issue":"8","key":"10.1016\/j.jinf.2026.106715_bib9","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1111\/hepr.13504","article-title":"Japan Society of Hepatology guidelines for the management of hepatitis B virus infection: 2019 update","volume":"50","author":"Drafting Committee for Hepatitis Management Guidelines tJSoH","year":"2020","journal-title":"Hepatol Res"},{"issue":"23","key":"10.1016\/j.jinf.2026.106715_bib10","doi-asserted-by":"crossref","first-page":"2218","DOI":"10.1056\/NEJMcps1212211","article-title":"Clinical problem-solving. D is for delay","volume":"371","author":"Kapoor","year":"2014","journal-title":"N Engl J Med"},{"issue":"9","key":"10.1016\/j.jinf.2026.106715_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0184550","article-title":"Randomized prospective study evaluating tenofovir disoproxil fumarate prophylaxis against hepatitis B virus reactivation in anti-HBc-positive patients with rituximab-based regimens to treat hematologic malignancies: the Preblin study","volume":"12","author":"Buti","year":"2017","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.jinf.2026.106715_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/jmv.28452","article-title":"Prophylactic tenofovir alafenamide for hepatitis B virus reactivation and reactivation-related hepatitis","volume":"95","author":"Suda","year":"2023","journal-title":"J Med Virol"},{"issue":"4","key":"10.1016\/j.jinf.2026.106715_bib13","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jhep.2017.11.039","article-title":"96\u00a0weeks treatment of tenofovir alafenamide vs. tenofovir disoproxil fumarate for hepatitis B virus infection","volume":"68","author":"Agarwal","year":"2018","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106715_bib14","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1007\/s12072-025-10875-7","article-title":"Three-year overall survival in unresectable hepatocellular carcinoma treated with atezolizumab plus bevacizumab","volume":"19","author":"Ohara","year":"2025","journal-title":"Hepatol Int"},{"issue":"5","key":"10.1016\/j.jinf.2026.106715_bib15","article-title":"Serum FGF21 as a predictor of response to atezolizumab and bevacizumab in HCC","volume":"7","author":"Kohya","year":"2025","journal-title":"JHEP Rep"},{"issue":"2","key":"10.1016\/j.jinf.2026.106715_bib16","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1159\/000527759","article-title":"Low baseline CXCL9 predicts early progressive disease in unresectable HCC with atezolizumab plus bevacizumab treatment","volume":"12","author":"Hosoda","year":"2023","journal-title":"Liver Cancer"},{"issue":"2","key":"10.1016\/j.jinf.2026.106715_bib17","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00535-020-01750-3","article-title":"Tenofovir-disoproxil-fumarate modulates lipid metabolism via hepatic CD36\/PPAR-alpha activation in hepatitis B virus infection","volume":"56","author":"Suzuki","year":"2021","journal-title":"J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106715_bib18","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","article-title":"Revised equations for estimated GFR from serum creatinine in Japan","volume":"53","author":"Matsuo","year":"2009","journal-title":"Am J Kidney Dis"},{"issue":"2","key":"10.1016\/j.jinf.2026.106715_bib19","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1002\/hep.27609","article-title":"Recent US Food and Drug Administration warnings on hepatitis B reactivation with immune-suppressing and anticancer drugs: just the tip of the iceberg?","volume":"61","author":"Di Bisceglie","year":"2015","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.jinf.2026.106715_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12072-015-9675-4","article-title":"Asian-Pacific clinical practice guidelines on the management of hepatitis B: a 2015 update","volume":"10","author":"Sarin","year":"2016","journal-title":"Hepatol Int"},{"issue":"6","key":"10.1016\/j.jinf.2026.106715_bib21","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1002\/hep.26718","article-title":"Chemotherapy-induced hepatitis B reactivation in lymphoma patients with resolved HBV infection: a prospective study","volume":"59","author":"Hsu","year":"2014","journal-title":"Hepatology"},{"issue":"5","key":"10.1016\/j.jinf.2026.106715_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.jhep.2017.04.008","article-title":"Hepatitis B virus reactivation during hepatitis C direct-acting antiviral therapy in patients with previous HBV infection","volume":"67","author":"Kawagishi","year":"2017","journal-title":"J Hepatol"},{"issue":"12","key":"10.1016\/j.jinf.2026.106715_bib23","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1111\/jvh.12737","article-title":"Comparing the risk of hepatitis B virus reactivation between direct-acting antiviral therapies and interferon-based therapies for hepatitis C","volume":"24","author":"Kawagishi","year":"2017","journal-title":"J Viral Hepat"},{"issue":"10","key":"10.1016\/j.jinf.2026.106715_bib24","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/hepr.13936","article-title":"Recent prevalence and characteristics of patients with hepatitis delta virus in Hokkaido, Japan","volume":"53","author":"Sasaki","year":"2023","journal-title":"Hepatol Res"},{"issue":"5","key":"10.1016\/j.jinf.2026.106715_bib25","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s12072-021-10239-x","article-title":"APASL clinical practice guideline on hepatitis B reactivation related to the use of immunosuppressive therapy","volume":"15","author":"Lau","year":"2021","journal-title":"Hepatol Int"},{"issue":"1","key":"10.1016\/j.jinf.2026.106715_bib26","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1053\/j.gastro.2014.10.039","article-title":"American Gastroenterological Association Institute guideline on the prevention and treatment of hepatitis B virus reactivation during immunosuppressive drug therapy","volume":"148","author":"Reddy","year":"2015","journal-title":"Gastroenterology"},{"issue":"33","key":"10.1016\/j.jinf.2026.106715_bib27","doi-asserted-by":"crossref","first-page":"4942","DOI":"10.3748\/wjg.v29.i33.4942","article-title":"Prevention and management of hepatitis B virus reactivation in patients with hematological malignancies in the targeted therapy era","volume":"29","author":"Mak","year":"2023","journal-title":"World J Gastroenterol"},{"issue":"6","key":"10.1016\/j.jinf.2026.106715_bib28","first-page":"1371","article-title":"Occult hepatitis B infection - unveiling clinical burden and new diagnostic strategies","volume":"19","author":"Soriano","year":"2025","journal-title":"Expert Rev Gastroenterol Hepatol"},{"issue":"11","key":"10.1016\/j.jinf.2026.106715_bib29","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1080\/14787210.2025.2580455","article-title":"The cascade of care for hepatitis B - any lessons from the HIV field?","volume":"23","author":"Soriano","year":"2025","journal-title":"Expert Rev Anti-Infect Ther"},{"issue":"5","key":"10.1016\/j.jinf.2026.106715_bib30","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1111\/cas.14846","article-title":"Prophylactic antiviral therapy for hepatitis B virus surface antigen-positive patients with diffuse large B-cell lymphoma treated with rituximab-containing chemotherapy","volume":"112","author":"Yamauchi","year":"2021","journal-title":"Cancer Sci"},{"issue":"23","key":"10.1016\/j.jinf.2026.106715_bib31","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2014.15704","article-title":"Entecavir vs lamivudine for prevention of hepatitis B virus reactivation among patients with untreated diffuse large B-cell lymphoma receiving R-CHOP chemotherapy: a randomized clinical trial","volume":"312","author":"Huang","year":"2014","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jinf.2026.106715_bib32","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1182\/blood-2018-10-878892","article-title":"Tenofovir vs lamivudine for the prevention of hepatitis B virus reactivation in advanced-stage DLBCL","volume":"133","author":"Picardi","year":"2019","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.jinf.2026.106715_bib33","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.ejim.2014.06.028","article-title":"The role of tenofovir in preventing and treating hepatitis B virus (HBV) reactivation in immunosuppressed patients. A real life experience from a tertiary center","volume":"25","author":"Koskinas","year":"2014","journal-title":"Eur J Intern Med"}],"container-title":["Journal of Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344532600040X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016344532600040X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T10:59:37Z","timestamp":1778669977000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016344532600040X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4]]},"references-count":33,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S016344532600040X"],"URL":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106715","relation":{},"ISSN":["0163-4453"],"issn-type":[{"value":"0163-4453","type":"print"}],"subject":[],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tenofovir alafenamide prevents HBV reactivation in anticancer\/immunosuppression: 24-month multicentre prospective study","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jinf.2026.106715","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd on behalf of British Infection Association.","name":"copyright","label":"Copyright"}],"article-number":"106715"}}